The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial

In this 3-year, open-label, multicenter study, 57 maintenance heart transplant recipients (>1 year after transplant) with renal insufficiency (eGFR 30–60 mL/min/1.73 m(2)) were randomized to start everolimus with CNI withdrawal (N = 29) or continue their current CNI-based immunosuppression (N = 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Keer, Jan, Derthoo, David, Van Caenegem, Olivier, De Pauw, Michel, Nellessen, Eric, Duerinckx, Nathalie, Droogne, Walter, Vörös, Gábor, Meyns, Bart, Belmans, Ann, Janssens, Stefan, Van Cleemput, Johan, Vanhaecke, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337890/
https://www.ncbi.nlm.nih.gov/pubmed/28316834
http://dx.doi.org/10.1155/2017/6347138

Ejemplares similares

Ejemplares similares